Sfoglia per Autore
PI-PLCbeta1 Expression in Patients with High-Risk Myelodysplastic Syndromes Is Affected by Azacitidine Treatment.
2007 Carlo Finelli; Matilde Y. Follo; Costanza Bosi; Sara Mongiorgi; Cristina Clissa; Giovanni Martinelli; Michele Baccarani; Alberto M. Martelli; Lucio Cocco
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation
2007 Follo, Matilde Y.; Mongiorgi, Sara; Bosi, Costanza; Cappellini, Alessandra; Finelli, Carlo; Chiarini, Francesca; Papa, Veronica; Libra, Massimo; Martinelli, Giovanni; Cocco, Lucio; Martelli, Alberto M.
PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes
2008 Follo MY; Finelli C; Bosi C; Martinelli G; Mongiorgi S; Baccarani M; Manzoli L; Blalock WL; Martelli AM; Cocco L
Nuclear phospholipase C beta1 and cellular differentiation.
2008 Faenza I; Bregoli L; Ramazzotti G; Gaboardi G; Follo MY; Mongiorgi S; Billi AM; Manzoli L; Martelli AM; Cocco L.
PKR is activated in MDS patients and its subcellular localization depends on disease severity.
2008 Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Martinelli G; Blalock WL; Cocco L; Martelli AM.
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resisten human T-acute leukemia cells by a JNK-dependent mechanism
2008 Chiarini F.; Del Sole M.; Mongiorgi S.; Gaboardi G.C.; Cappellini A.; Mantovani I.; Follo M.Y.; McCubrey J.A.; Martelli A.M.
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS.
2009 Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Testoni N; Chiarini F; Ramazzotti G; Baccarani M; Martelli AM; Manzoli L; Martinelli G; Cocco L
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients.
2009 Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Francesca Chiarini; Stefania Paolini; Michele Baccarani; Giovanni Martinelli; Lucia Manzoli; Alberto M. Martelli; Carlo Finelli; Lucio Cocco
Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia.
2009 Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martelli AM; Cocco L.
Nuclear inositide signaling in myelodysplastic syndromes.
2010 Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli AM; Cocco L
Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment
2010 Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Carla Filì; Chiara Colombi; Michele Baccarani; Giovanni Martinelli; Domenico Russo; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco
Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response
2011 C. Finelli; C. Clissa; M. Follo; A. Curti; S. Paolini; C. Papayannidis; S. Mongiorgi; S. Parisi; L. Manzoli; G. Martinelli; L. Cocco; M. Baccarani
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients
2011 Matilde Y Follo; Cristina Clissa; Sara Mongiorgi; Francesca Chiarini; Michele Baccarani; Giovanni Martinelli; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco
Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients
2011 Matilde Y. Follo; Sara Mongiorgi; Cristina Clissa; Costanza Bosi; Michele Baccarani; Giovanni Martinelli; Patrizia Santi; Giulia Ramazzotti; Anna Maria Billi; Lucia Manzoli; Carlo Finelli; Lucio Cocco
PROLONGED HEMATOLOGIC AND MOLECULAR RESPONSE AFTER A LIMITED NUMBER OF AZACITIDINE CYCLES IN LOW-RISK MYELODYSPLASTIC SYNDROMES
2011 C Finelli;C Clissa; M Follo; D Russo; C Filì; A Curti;S Paolini; C Bosi; S Mongiorgi; L Manzoli; C Papayannidis; S Parisi; G Martinelli; L Cocco; M Baccarani
Role of inositide signalling regulation in higher-risk MDS patients during epigenetic therapy
2011 M.Y. Follo; S. Mongiorgi; C. Clissa; C. Bosi; M. Baccarani; G. Martinelli; L. Manzoli; C. Finelli; L. Cocco
EFFECT OF LENALIDOMIDE ON INOSITIDE-DEPENDENT SIGNAL TRANSDUCTION PATHWAYS
2011 Follo MY;Mongiorgi S; Clissa C; Baccarani M; Paolini S; Martinelli G; Manzoli L; Finelli C; Cocco L
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES
2011 Finelli C; Clissa C; Follo MY; Curti A;Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Bosi C; Manzoli L; Martinelli G; Cocco L; Baccarani M
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes
2011 Follo MY; Finelli C; Mongiorgi S; Clissa C; Chiarini F; Ramazzotti G; Paolini S; Martinelli G; Martelli AM; Cocco L
Effect of azacitidine on inositide-dependent signalling pathways in low-risk MDS patients
2011 M.Y. Follo; S. Mongiorgi; C. Clissa; C. Filì; C. Colombi; M. Baccarani; G. Martinelli; M. Gobbi; L. Manzoli; D. Russo; C. Finelli; L. Cocco
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| PI-PLCbeta1 Expression in Patients with High-Risk Myelodysplastic Syndromes Is Affected by Azacitidine Treatment. | Carlo Finelli; Matilde Y. Follo; Costanza Bosi; Sara Mongiorgi; Cristina Clissa; Giovanni Martine...lli; Michele Baccarani; Alberto M. Martelli; Lucio Cocco | 2007-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation | Follo, Matilde Y.; Mongiorgi, Sara; Bosi, Costanza; Cappellini, Alessandra; Finelli, Carlo; Chiar...ini, Francesca; Papa, Veronica; Libra, Massimo; Martinelli, Giovanni; Cocco, Lucio; Martelli, Alberto M. | 2007-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes | Follo MY; Finelli C; Bosi C; Martinelli G; Mongiorgi S; Baccarani M; Manzoli L; Blalock WL; Marte...lli AM; Cocco L | 2008-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Nuclear phospholipase C beta1 and cellular differentiation. | Faenza I; Bregoli L; Ramazzotti G; Gaboardi G; Follo MY; Mongiorgi S; Billi AM; Manzoli L; Martel...li AM; Cocco L. | 2008-01-01 | FRONTIERS IN BIOSCIENCE | - | 1.01 Articolo in rivista | - |
| PKR is activated in MDS patients and its subcellular localization depends on disease severity. | Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Martinelli G; Blalock WL; Cocco L; Martelli AM. | 2008-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resisten human T-acute leukemia cells by a JNK-dependent mechanism | Chiarini F.; Del Sole M.; Mongiorgi S.; Gaboardi G.C.; Cappellini A.; Mantovani I.; Follo M.Y.; M...cCubrey J.A.; Martelli A.M. | 2008-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. |
Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Testoni N; Chiarini F; Ramazzotti G; Baccara...ni M; Martelli AM; Manzoli L; Martinelli G; Cocco L |
2009-01-01 | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | - | 1.01 Articolo in rivista | - |
| Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients. | Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Francesca Chiarini; Stefania Paolini; Michele B...accarani; Giovanni Martinelli; Lucia Manzoli; Alberto M. Martelli; Carlo Finelli; Lucio Cocco | 2009-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
| Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia. | Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martell...i AM; Cocco L. | 2009-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Nuclear inositide signaling in myelodysplastic syndromes. | Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli ...AM; Cocco L | 2010-01-01 | JOURNAL OF CELLULAR BIOCHEMISTRY | - | 1.01 Articolo in rivista | - |
| Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment | Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Carla Filì; Chiara Colombi; Michele Baccarani; ...Giovanni Martinelli; Domenico Russo; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco | 2010-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
| Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response | C. Finelli; C. Clissa; M. Follo; A. Curti; S. Paolini; C. Papayannidis; S. Mongiorgi; S. Parisi; ...L. Manzoli; G. Martinelli; L. Cocco; M. Baccarani | 2011-01-01 | LEUKEMIA RESEARCH | - | 4.02 Riassunto (Abstract) | - |
| Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients | Matilde Y Follo; Cristina Clissa; Sara Mongiorgi; Francesca Chiarini; Michele Baccarani; Giovanni... Martinelli; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco | 2011-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
| Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients | Matilde Y. Follo; Sara Mongiorgi; Cristina Clissa; Costanza Bosi; Michele Baccarani; Giovanni Mar...tinelli; Patrizia Santi; Giulia Ramazzotti; Anna Maria Billi; Lucia Manzoli; Carlo Finelli; Lucio Cocco | 2011-01-01 | ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY | - | 4.01 Contributo in Atti di convegno | - |
| PROLONGED HEMATOLOGIC AND MOLECULAR RESPONSE AFTER A LIMITED NUMBER OF AZACITIDINE CYCLES IN LOW-RISK MYELODYSPLASTIC SYNDROMES |
C Finelli;C Clissa; M Follo; D Russo; C Filì; A Curti;S Paolini; C Bosi; S Mongiorgi; L Manzoli;... C Papayannidis; S Parisi; G Martinelli; L Cocco; M Baccarani |
2011-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Role of inositide signalling regulation in higher-risk MDS patients during epigenetic therapy | M.Y. Follo; S. Mongiorgi; C. Clissa; C. Bosi; M. Baccarani; G. Martinelli; L. Manzoli; C. Finelli...; L. Cocco | 2011-01-01 | LEUKEMIA RESEARCH | - | 4.01 Contributo in Atti di convegno | - |
| EFFECT OF LENALIDOMIDE ON INOSITIDE-DEPENDENT SIGNAL TRANSDUCTION PATHWAYS |
Follo MY;Mongiorgi S; Clissa C; Baccarani M; Paolini S; Martinelli G; Manzoli L; Finelli C; Cocco L |
2011-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
| AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES |
Finelli C; Clissa C; Follo MY; Curti A;Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Bosi C; ...Manzoli L; Martinelli G; Cocco L; Baccarani M |
2011-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
| Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes | Follo MY; Finelli C; Mongiorgi S; Clissa C; Chiarini F; Ramazzotti G; Paolini S; Martinelli G; Ma...rtelli AM; Cocco L | 2011-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Effect of azacitidine on inositide-dependent signalling pathways in low-risk MDS patients | M.Y. Follo; S. Mongiorgi; C. Clissa; C. Filì; C. Colombi; M. Baccarani; G. Martinelli; M. Gobbi; ...L. Manzoli; D. Russo; C. Finelli; L. Cocco | 2011-01-01 | LEUKEMIA RESEARCH | - | 4.01 Contributo in Atti di convegno | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile